According to Waters Corporation's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 30.2221. At the end of 2022 the company had a P/E ratio of 29.0.
Year | P/E ratio | Change |
---|---|---|
2022 | 29.0 | -12.34% |
2021 | 33.1 | 12.11% |
2020 | 29.5 | 11.7% |
2019 | 26.4 | 8.32% |
2018 | 24.4 | -96.97% |
2017 | 805 | 3775.35% |
2016 | 20.8 | -11.87% |
2015 | 23.6 | 7.68% |
2014 | 21.9 | 15.35% |
2013 | 19.0 | 14.78% |
2012 | 16.5 | 6.49% |
2011 | 15.5 | -17.3% |
2010 | 18.8 | 2.09% |
2009 | 18.4 | 62.54% |
2008 | 11.3 | -61.8% |
2007 | 29.6 | 30.02% |
2006 | 22.8 | 6.65% |
2005 | 21.4 | -15.11% |
2004 | 25.2 | 5.45% |
2003 | 23.9 | 24.87% |
2002 | 19.1 | -56.61% |
2001 | 44.0 |
Company | P/E ratio | P/E ratio differencediff. | Country |
---|---|---|---|
Thermo Fisher Scientific TMO | 37.9 | 25.37% | ๐บ๐ธ USA |
Agilent Technologies A | 38.0 | 25.71% | ๐บ๐ธ USA |
General Electric GE | 20.5 | -32.07% | ๐บ๐ธ USA |
Mettler-Toledo
MTD | 33.2 | 9.85% | ๐บ๐ธ USA |
Danaher DHR | 31.1 | 3.03% | ๐บ๐ธ USA |
PerkinElmer
PKI | 15.0 | -50.48% | ๐บ๐ธ USA |
Bruker BRKR | 43.3 | 43.24% | ๐บ๐ธ USA |
Bio-Rad Laboratories BIO | -60.5 | -300.07% | ๐บ๐ธ USA |
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.